Laboratory Information System
The award-winning XiFin LIS is a fully scalable SaaS-based laboratory information system that offers multi-specialty workflows, a comprehensive toolset, flexible and secure connectivity and leading-edge capabilities that optimize high volume and complex testing labs.
LIS Quick Reference Guide
XiFin LIS Quick Reference Guide shares six key areas to consider when discussing your future growth plans for your laboratory and LIS needs.
Helping Labs Create More Value and Better Integrate with the Broader Healthcare Ecosystem
In response to value-based and patient-centered coordinated care models, the healthcare industry is shifting. Accelerating the shift is the exponential growth in the adoption of genomic testing and personalized medicine using next-generation sequencing (NGS). Laboratories must adapt their existing processes to meet the challenge of implementing and reporting these high complexity tests. Since diagnostic insights have the potential to reduce overall healthcare costs and improve patient care – it is crucial that laboratories better integrate with the healthcare ecosystem. These demands are driving the need for more interaction and greater communication across all healthcare and diagnostic providers.
In this environment, a SaaS-based LIS is a critical and central component of an efficient laboratory operations strategy. Laboratories need their technology infrastructure to support new initiatives such as NGS data analytics & reporting as well as artificial intelligence (AI) in digital pathology in addition to optimizing their operations to enable them to easily respond to changing business demands such as the need for prior-authorization services. There’s no doubt that a laboratory’s LIS is the day-to-day workhorse and must be architected to meet these new demands. Those that are proactively addressing challenges and opportunities in the healthcare industry view their LIS as a critical success factor and an investment.
New Revenue Models
XiFin LIS increases laboratory testing capacity, shortens turnaround time, enables the creation of new revenue models, improves operational efficiencies, and makes it easier to connect to other healthcare partners. XiFin's modular approach provides laboratories the flexibility to choose only those workflows they require to meet their immediate needs and to readily add more when required to scale.
Improve Operational Efficiency
Advanced Capabilities Extend the LIS Beyond the Laboratory
Test-Specific Automation Gets You Started Quickly
XiFin LIS automates and manages your diagnostic workflows—regardless of complexity or volume. With configuration driven automated workflow modules supporting 17 different testing specialties, it is easy to get started.
Anatomic Pathology
Amid changing healthcare models, pathologists are seeing increasing demand for comprehensive reporting, collaboration, and data sharing to support multidisciplinary teams.
Clinical Pathology
Clinical and toxicology laboratories are under pressure to optimize operational efficiencies in an increasingly challenging reimbursement environment. Higher throughput without compromising quality requires a flexible laboratory information system that can manage significant workflow variety, actively manage worklists and sample progress and take advantage of electronic connectivity from the EMR through the billing process.
Molecular Diagnostics
The advance in human genotyping and a transition to a value-based model is driving growth in molecular diagnostic (MDx) testing and complementary services. This expansion is creating data and workflow management, reporting, compliance, and specialty testing reimbursement policy issues that must be solved for today’s MDx labs to thrive.
Genomics
The frequency and cost of adverse drug events (ADEs), coupled with a shift towards a value-based healthcare model is forcing a rapid change in the healthcare landscape. As a result, the utility and application in the clinical environment of pharmacogenomics (PGx) and next-generation sequencing (NGS) test is increasing
To be successful, PGx and NGS focused laboratories must be equipped to solve the data and workflow management, reporting, compliance, and challenging reimbursement policies that are being created.
Stay Competitive in an Increasingly Complex Environment
Combining processing efficiency, workflow optimization, quality assurance, and data validation, XiFin LIS enables laboratories to stay competitive in an increasingly complex environment. Additionally, the cloud-based SaaS architecture removes costly IT requirements, easily scales to meet the needs of laboratories of any size, and facilitates collaboration and information sharing across systems in a two-way "digital conversation."
In as little as 45 days, XiFin LIS can be integrated and configured to connect all laboratory operational components allowing for a global, real-time view of lab activities and the automation of critical workflow steps.
This connectivity allows for a single point of entry for all laboratory processes via an intuitive, laboratory-friendly solution. Streamlining these procedures and increasing efficiencies allows laboratory staff to focus their time on improving patient care and outcomes, and less time on data entry and paper shuffling.
XiFin LIS also includes the following Input screens and functions:
Thinking of Building or Upgrading Your Own LIS? Read This First.
The Build vs Buy Conundrum of Laboratory Information Systems
SaaS-based information systems eradicate system silos and allow labs to more easily integrate, communicate and exchange information with other systems, as opposed to the siloed solutions labs build for themselves. Plus, you never have to worry if the system expert suddenly is no longer available. For more detail on the importance of investing in SaaS-based LIS systems, read XiFin’s “Buy vs. Build” white paper.
Download White PaperSingle Integrated Platform, More Efficient Operations, Faster & More Accurate Claims, Richer Data
XiFin LIS is part of a complete cloud-based laboratory platform that manages data from patient to payment. This platform includes XiFin RPM for optimized revenue cycle management (RCM). Together, the integrated clinical data generated by XiFin LIS and the detailed financial information from XiFin RPM form the basis for insightful business intelligence that will help your laboratory thrive. Used together, the reimbursement process is expedited, as data is exchanged in real-time along with supporting documentation for clinical evidence and appeals support.
Meet Some of Our Newest Strategic Partners
Fabric Genomics is pleased to partner with XiFin to enable seamless, rapid, and scalable NGS testing. With integrated XiFin-Fabric workflows, labs can streamline going from accessioning to interpreting genomic data to generating clinical case reports. Fabric Genomics’ market-leading AI helps labs dramatically improve their diagnostic rates and accelerate turnaround time. With reimbursement for NGS testing established and expanding, Fabric Genomics and XiFin's partnership enables labs to quickly launch and scale NGS testing and flexibly grow their testing menus.
The partnership between Glidian and XiFin has been able to deliver one of the most automated end-to-end revenue cycle solutions available on the market today. The two platforms exchange data seamlessly to automate the extremely manual prior authorization process. Our customers have been able to see significant improvements in reimbursement rate and time.
In addition to its critical role in advancing whole slide diagnosis in this age of precision medicine, digital pathology software is enabling unimagined efficiencies for pathologists and labs. The integration of our Concentriq digital pathology platform with XiFin LIS creates the type of seamless workflow that makes it easier than ever to capitalize on the benefits of digital pathology software, radically improving lab economics going forward.
Through our partnership with XiFin, the combined solutions will improve efficiencies, workflows and will benefit the bottom line for many diagnostic providers,” said Jaideep Tandon, CEO, and co-founder of Infinx. “Our prior authorization software and specialists that support several healthcare specialties are able to obtain a prior authorization 98% of the time resulting in a 55% decrease in costs, and a 10% boost in reimbursements. By integrating our software with XiFin RPM, our technologies will address a huge reimbursement bottleneck by automating the prior authorization workflow.
Comprehensive Reporting That Drives Loyalty and Engagement with Your Clients
Comprehensive Reporting That Drives Loyalty and Engagement with Your Clients
Comprehensive Reporting That Drives Loyalty and Engagement with Your Clients
Comprehensive consolidated reports maximize your value and impact - combine all individual testing results into a single comprehensive summary report.
Download Report
XiFin LIS Integrates and Interoperates with Many Purpose-built Capabilities
Simplifying the Prior Authorization Process for Laboratories, Physicians, and Patients is a Win, Win, Win
According to a recent AMA survey, 86% of physicians indicated that the burden of prior authorization was high- or extremely high. Ninety-one percent indicated that the prior authorization process resulted in a significant- or a somewhat negative impact on patient clinical outcomes. Recognizing the impact that the process imposes on the healthcare system, XiFin has partnered with Glidian and Infinx to ease the prior authorization burden for our XiFin LIS customers and their clients. Integrated with the LIS platform, ordering physicians can initiate the prior authorization process directly from their LIS interface. From there, the process is completely automated, sending a prior authorization approval code to the laboratory as soon as the process is completed. Never before has prior authorization been so simple, a benefit for laboratories, physicians and patients.
Increase Revenue and Improve Efficiencies Using XiFin LIS and Proscia’s Concentriq™ Digital Pathology
The future of pathology is digital: those who are realizing the promise of digital pathology are seeing a tremendous benefit for their laboratories and patient outcomes.
Traditional microscopy tools are not well equipped to handle the applications of the modern lab. Proscia’s Concentriq™ digital pathology platform and pipeline of AI applications are transforming the economics and practice of pathology, putting the power of modern, data-centric systems into the hands of every lab.
That’s why we have partnered with Proscia to provide AI-enabled workflow solutions with XiFin LIS. The Proscia Concentriq platform seamlessly integrates with XiFin solutions and includes joint customer support.
Our combined capabilities enable a robust workflow that further increases revenue through the optimization and efficiency gains of a pathologist’s routine workflow in clinical and research settings.
Drive laboratory-level insight from pathology and histology analytics
Transforming Healthcare Through AI-Driven Clinical Genomic Insights Powered by Fabric Genomics
Next-generation sequencing testing enables significant advances in precision medicine and resulting patient outcomes. XiFin LIS is the only SaaS-based LIS platform that offers multi-specialty workflows and collaboration tools necessary to support precision medicine programs. Genomic data is much more complex than data generated traditional molecular assays. Fabric Genomics delivers a highly scalable AI-driven platform to analyze and interpret this complex genomic data.
Through XiFin ’s partnership with Fabric Genomics it is easier than ever for labs and hospital to develop, deploy, and scale genomic testing. XiFin LIS has integrated Fabric Genomics’ AI-driven genomic data interpretation in inherited disease, rare disease and oncology within the XiFin LIS workflow, delivering physician-ready clinical reports for any genomic test.
Enhancing Test Utilization
Entering accurate billing codes to receive reimbursement for diagnostic claims has become increasingly more difficult. With more than 2000 possible lab tests and over 70,000 ICD10 codes from which to choose, claim denials are on the rise, lengthening the timeline from diagnosis to treatment and reducing reimbursements.
XiFin has partnered with Medical Database, Inc. to support providers in more accurately selecting the most relevant diagnostics tests for their patients. Medical Database’s Laboratory Decision Support (LDS™) platform utilizes a proprietary (patent pending) ranking system which scores potential tests for any given disease and assigns an easily interpretable numerical and color-coded score, based on clinical relevance, medical necessity, and testing indication. This medical evidence-based ranking system to assist healthcare providers in selecting and ordering the correct and most relevant tests based on disease and ICD10 codes.